Women still not aware of epilepsy medicine risk in pregnancy
Almost 1 in 5 (18%) women currently taking the epilepsy medication sodium valproate do not know it can harm the development and physical health of their unborn child should they become pregnant
more than a quarter (28%) of women taking the epilepsy drug have not been given information about risks for their unborn child
more than two thirds (68%) of women taking the epilepsy drug have not received specially produced valproate materials released in February 2016
Charities call on government to make annual reviews mandatory for women taking the drug
Children affected by sodium valproate
The BBC is planning to run several news broadcasts about the European Medicines Agency (EMA) public hearing into sodium valproate taking place in London on 26 September 2017.
Epilepsy Society's Clare Pelham discusses sodium valproate and EMA public hearing on BBC News
Watch and listen to Epilepsy Society's CEO Clare Pelham discussing our sodium valproate survey and the European Medicine's Agency public hearing into the epilepsy drug on various BBC News programmes over the last few days.
Epilepsy Society's medical director says don't panic over current shortages of epilepsy drugs
No need to panic over current shortages of some epilepsy medications
Swiching between different types of levtiracetam should not be a problem
Switching to a different type of clobazam should be done in consultation with a doctor
Latest update on supply problems
Research using Apple watch links epileptic seizures to stress and missed sleep
New research using an Apple Watch app to track seizures in people with epilepsy has found that the most common triggers are often stress and missed sleep.
Charity calls for greater public awareness as people with epilepsy are accused of being drunk following a seizure
As dry January ends, Epilepsy Society is urging the public to think twice before assuming that a person who is staggering around in a confused state, is drunk.